Probiotics Counterfeit! Study Finds Most Labels Mislead Customers

Hazan et al., ACG 2023, Oct 2023
Probiotics for COVID-19
19th treatment shown to reduce risk in March 2021, now with p = 0.00000044 from 29 studies.
Lower risk for mortality, hospitalization, progression, recovery, and cases.
No treatment is 100% effective. Protocols combine treatments.
6,300+ studies for 210+ treatments. c19early.org
Meta Analysis
Analysis of 26 commercially available probiotics with labels indicating Bifidibacteria content, showing only five contained Bifidobacterium in sufficient concentration for a therapeutic effect, and showing presence of a pathogen in one product. Authors suggest that currently prebiotics and other nutraceuticals may be more reliable for increasing levels of beneficial bacteria.
Probiotic efficacy depends on the specific strains used. Specific microbes may decrease or increase COVID-19 risk1.
Important missing comments or errors? Let us know.
Study covers probiotics and ivermectin.
Hazan et al., 22 Oct 2023, preprint, 2 authors.
Please send us corrections, updates, or comments. c19early involves the extraction of 200,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
  or use drag and drop   
Submit    
Post
Share
@CovidAnalysis
FAQ
Public domain CC0 1.0